Search

West Pharmaceutical Services Inc

Chiusa

SettoreSettore sanitario

355.17 2.71

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

344.05

Massimo

356.12

Metriche Chiave

By Trading Economics

Entrata

15M

154M

Vendite

27M

872M

P/E

Media del settore

43.474

56.597

EPS

2.37

Rendimento da dividendi

0.25

Margine di Profitto

17.654

Dipendenti

10,800

EBITDA

-39M

179M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+17.9% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

0.25%

2.18%

Utili prossimi

22 ott 2026

Prossima data del Dividendo

18 nov 2026

Prossima data del' Ex Dividendo

11 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-965M

24B

Apertura precedente

352.46

Chiusura precedente

355.17

Notizie sul Sentiment di mercato

By Acuity

100%

0%

322 / 339 Classifica in Healthcare

West Pharmaceutical Services Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 set 2026, 20:01 UTC

News

UBS raised West Pharmaceutical Services' price target to $415, maintaining a "buy" rating. Shares are higher since Thursday's close despite earlier session declines.

10 set 2026, 20:51 UTC

West Pharmaceutical Services Inc shares are lower in after-market hours amid challenging broader market conditions and declining existing home sales for August.

9 set 2026, 20:07 UTC

West Pharmaceutical Services Inc. trades roughly flat amid a broader market trend, remaining near the lower end of its one-month range.

8 set 2026, 23:26 UTC

West Pharmaceutical Services Inc. shares are higher in after-market trading, showing modest gains since Tuesday's close despite no specific news to explain the movement.

4 set 2026, 19:36 UTC

West Pharmaceutical Services is declining amid broader market pressure from strong labor data and rising Treasury yields, with shares below their 20-day moving average.

3 set 2026, 22:01 UTC

West Pharmaceutical Services shares are higher in after-market trading as Treasury yields decline, easing concerns about rising borrowing costs impacting growth stocks.

2 set 2026, 23:51 UTC

West Pharmaceutical Services Inc shares are higher in after-market trading. The move occurs amid a weaker-than-expected ADP payrolls report, easing rate hike concerns.

1 set 2026, 23:51 UTC

West Pharmaceutical Services Inc shares are lower in after-hours trading, continuing a downward trend and trading below the 20-day moving average.

31 ago 2026, 20:07 UTC

News

West Pharmaceutical Services is higher, reflecting institutional trading activity amid expectations for interest rate hikes following the Jackson Hole Economic Symposium.

28 ago 2026, 23:11 UTC

West Pharmaceutical Services shares are higher in after-market trading, reaching a session high but remaining below their 20-day moving average.

27 ago 2026, 23:02 UTC

West Pharmaceutical Services Inc shares are higher in after-market hours. The broader market reflects a decline in initial jobless claims, indicating labor market strength.

26 ago 2026, 19:26 UTC

West Pharmaceutical Services Inc is trading higher amid positive market conditions, despite no specific company news driving today's activity.

25 ago 2026, 23:26 UTC

West Pharmaceutical Services Inc. shares are trading roughly flat after hours, amid broader market stability following a significant decline in crude oil prices.

24 ago 2026, 19:51 UTC

West Pharmaceutical Services Inc is trading higher today, remaining near the upper end of its one-month range and above its 20-day moving average.

21 ago 2026, 23:01 UTC

West Pharmaceutical Services Inc. shares are lower in after-market trading, remaining near the lower end of today's range and the upper end of their one-month range.

20 ago 2026, 20:06 UTC

West Pharmaceutical Services Inc shares are higher, continuing an upward trend since Wednesday. Broader market trends may be influencing investor sentiment in the life sciences sector.

19 ago 2026, 20:06 UTC

West Pharmaceutical Services Inc shares are rising amid a positive market backdrop, remaining above their 20-day moving average and near the upper end of their one-month range.

18 ago 2026, 19:36 UTC

West Pharmaceutical Services Inc. is trading slightly higher, maintaining a routine move within its one-month trading range. No specific news was identified.

17 ago 2026, 22:55 UTC

West Pharmaceutical Services shares are slightly higher in after-market hours, amid escalating geopolitical tensions and rising crude oil prices affecting market stability.

14 ago 2026, 23:01 UTC

West Pharmaceutical Services shares are lower in after-market hours, influenced by a decline in U.S. retail sales for July. No specific news was identified.

13 ago 2026, 23:36 UTC

West Pharmaceutical Services Inc. shares declined after-market, with no specific company news identified. Broader market sentiment may be influenced by unchanged producer prices.

12 ago 2026, 19:36 UTC

West Pharmaceutical Services is trading higher, supported by a slight increase in the core Consumer Price Index and an optimistic outlook for risk assets.

11 ago 2026, 19:26 UTC

West Pharmaceutical Services Inc is trading higher today, reflecting a gain since Monday. Market participants are watching upcoming U.S. inflation reports closely.

10 ago 2026, 23:46 UTC

West Pharmaceutical Services shares are higher in after-market trading, reaching a level near the upper end of their one-month range. No specific news was identified.

7 ago 2026, 19:46 UTC

West Pharmaceutical Services Inc is trading higher during Friday's session, reflecting market strength. Shares remain above their 20-day moving average despite an earlier pullback.

6 ago 2026, 20:51 UTC

West Pharmaceutical Services Inc. is roughly flat in after-market hours amid broader market declines and ahead of the upcoming non-farm payrolls report.

5 ago 2026, 19:56 UTC

West Pharmaceutical Services shares are trading higher amid broader market gains, influenced by recent declines in oil prices and potential supply resolution.

4 ago 2026, 20:51 UTC

West Pharmaceutical Services shares declined in after-hours trading, shifting downward despite an initial gain. No specific company news was identified for the movement.

3 ago 2026, 19:46 UTC

News

Citigroup raised its price target on West Pharmaceutical Services to $412, maintaining a Buy rating following strong quarterly results and increased revenue guidance.

31 lug 2026, 23:01 UTC

News

West Pharmaceutical Services shares are lower in after-market trading despite strong Q2 results and raised full-year guidance, reflecting mixed market sentiment.

Confronto tra pari

Modifica del prezzo

West Pharmaceutical Services Inc Previsione

Obiettivo di Prezzo

By TipRanks

17.9% in crescita

Previsioni per 12 mesi

Media 408.222 USD  17.9%

Alto 447 USD

Basso 365 USD

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per West Pharmaceutical Services Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

10 ratings

9

Acquista

1

Mantieni

0

Vendi

Sentiment

By Acuity

322 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat